Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples
Sponsor: Becton, Dickinson and Company
Terminated
Lower than anticipated rate of subject enrollment
Other terminated trials from Becton, Dickinson and Company
This NA trial investigates Uterine Cervical Neoplasm and is currently terminated or withdrawn. Becton, Dickinson and Company leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2018 — Jun 2018 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2017 — Feb 2018 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
May 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Becton, Dickinson and Company
For direct contact, visit the study record on ClinicalTrials.gov .